抗N-甲基-d-酸盐受体脑炎:见解和未来治疗方向
Yoji Hoshina1, Tammy L Smith2, Melissa A Wright3
1Department of Neurology, University of Utah, Salt Lake City, UT, USA.
Trends in molecular medicine
|October 8, 2025
概括
抗N-甲基-D-酸盐受体 (NMDAR) 脑炎缺乏FDA批准的治疗方法. 研究重点是改善诊断,瘤监测和开发新型疗法,如B细胞和IL-6向治疗.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
背景情况:
- 抗N-甲基-D-酸盐受体 (NMDAR) 脑炎是一种已知的自身免疫神经系统疾病.
- 尽管在诊断和治疗建议方面取得了进展,但目前还没有FDA批准的治疗方法.
研究的目的:
- 审查最近在抗NMDAR脑炎的发展.
- 讨论当前和新兴的研究疗法.
主要方法:
- 文献综述综合了最近的研究和临床试验.
- 对诊断标准,预后指标和治疗结果的分析.
主要成果:
- 强调了血清抗体检测的局限性和定制瘤监测的必要性.
- 在不同的人口中注意到流行病学变异.
- 预测指标,如NEOS得分,可以改善结果预测,80%的预测结果是有利的.
结论:
- 持续的赤字强调了需要更好的治疗策略.
- 目前正在进行的临床试验正在评估针对B细胞和IL-6的向疗法.
- 该综述综合了当前的知识和对抗NMDAR脑炎治疗的未来方向.
更多相关视频
10:19High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
16.7K
06:19Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
4.5K
相关概念视频
Antiepileptic Drugs: Glutamate Antagonists
893
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
893
Alzheimer's Disease: Treatment
822
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
822
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
558
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
558
